Cidara TherapeuticsCDTX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 27 institutions reported holding Cidara Therapeutics Inc. (CDTX) in their 13F filings, up 2 from Q2 2024. 6 opened new positions and 4 sold out. The largest holders were Bain Capital Life Sciences Investors, LLC ($7.6M), Ra Capital Management, L.P. ($7.6M) and BVF Inc. ($7.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Cidara Therapeutics Inc.
- CUSIP
- 171757206
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $16.1M |
| Exits | 4 | $158K |
All 13F filers, Q2 2024 → Q3 2024: 1,908,845 shares bought and 13,186 shares sold, net +1,895,659 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Bain Capital Life Sciences Investors, LLC | 0.79% | New | 703,080 | $7.6M |
| Ra Capital Management, L.P. | 0.09% | New | 703,080 | $7.6M |
| BVF Inc. | 0.22% | Add +104.9% | 703,065 | $7.6M |
| Monashee Investment Management LLC | 0.44% | No change | 369,099 | $4.0M |
| Checkpoint Capital L.P. | 0.97% | Add +25.4% | 182,426 | $2.0M |
| Vanguard Group Inc. | 0.00% | No change | 180,535 | $1.9M |
| Renaissance Technologies | 0.00% | Add +2.4% | 97,817 | $1.1M |
| Alethea Capital Management, LLC | 0.62% | No change | 79,908 | $859K |
| 5AM Venture Management, LLC | 0.13% | No change | 56,725 | $610K |
| Geode Capital Management, LLC | 0.00% | Add +22.7% | 52,898 | $569K |
| BlackRock, Inc. | 0.00% | — | 48,920 | $526K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 42,755 | $460K |
| Northern Trust Corp. | 0.00% | New | 31,787 | $342K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +0.5% | 19,500 | $210K |
| Millennium Management | 0.00% | New | 13,919 | $150K |
| State Street Corp. | 0.00% | No change | 13,576 | $146K |
| UBS Group AG | 0.00% | Add +300.6% | 5,877 | $63K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +49.5% | 1,115 | $12K |
| Russell Investments Group, Ltd. | 0.00% | No change | 855 | $9K |
| Manchester Capital Management LLC | 0.00% | No change | 470 | $5K |
| Pacifica Partners Inc. | 0.00% | No change | 400 | $4K |
| Avion Wealth | 0.00% | New | 250 | $2K |
| Morgan Stanley | 0.00% | No change | 169 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 106 | $1K |
| Allworth Financial LP | 0.00% | No change | 40 | $430 |
| Bank of America Corp. | 0.00% | Add +14.7% | 39 | $419 |
| BNP Paribas Financial Markets | 0.00% | No change | 17 | $183 |
"% of holder's portfolio" is CDTX's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. the manager owns.